Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanoma.

Barailler H, Salomon G, Dutriaux C, Prey S, Gérard E, Dousset L, Mertens C, Beylot-Barry M, Meyer N, Pham-Ledard A.

J Geriatr Oncol. 2020 Mar 18. pii: S1879-4068(19)30392-3. doi: 10.1016/j.jgo.2020.03.003. [Epub ahead of print] No abstract available.

PMID:
32199777
2.

Reliable blood cancer cells' telomere length evaluation by qPCR.

Ropio J, Chebly A, Ferrer J, Prochazkova-Carlotti M, Idrissi Y, Azzi-Martin L, Cappellen D, Pham-Ledard A, Soares P, Merlio JP, Chevret E.

Cancer Med. 2020 Mar 6. doi: 10.1002/cam4.2816. [Epub ahead of print]

3.

[Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma].

Malmontet T, Dousset L, Gerard E, Ouhabrache N, Pham-Ledard A, Beylot-Barry M.

Ann Dermatol Venereol. 2020 Mar;147(3):228-232. doi: 10.1016/j.annder.2019.08.019. Epub 2019 Nov 30. French.

PMID:
31791649
4.

A case of potential radiation recall dermatitis induced by chemotherapy, following low-dose total-skin electron beam therapy.

Lamoureux C, Gerard E, Ouhabrache N, Toukal F, Pham-Ledard A, Beylot-Barry M.

Eur J Dermatol. 2019 Dec 1;29(6):671-672. doi: 10.1684/ejd.2019.3670. No abstract available.

PMID:
31774059
5.

Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.

Menguy S, Laharanne E, Prochazkova-Carlotti M, Gros A, Vergier B, Parrens M, Beylot-Barry M, Pham-Ledard A, Merlio JP.

Am J Surg Pathol. 2020 Mar;44(3):424-427. doi: 10.1097/PAS.0000000000001412. No abstract available.

PMID:
31764222
6.

Characteristics, Associated Diseases, and Management of Gram-negative Toe-web Infection: A French Experience.

Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, Chosidow O, Beylot-Barry M.

Acta Derm Venereol. 2019 Nov 1;99(12):1121-1126. doi: 10.2340/00015555-3315.

7.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.

Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M; Groupe de Cancérologie Cutanée, Groupe Français de Pneumo-Cancérologie, and Club Rhumatismes et Inflammations.

Arthritis Rheumatol. 2019 Dec;71(12):2100-2111. doi: 10.1002/art.41068. Epub 2019 Oct 21.

PMID:
31379105
8.

Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.

Ducharme O, Beylot-Barry M, Pham-Ledard A, Bohers E, Viailly PJ, Bandres T, Faur N, Frison E, Vergier B, Jardin F, Merlio JP, Gros A.

J Invest Dermatol. 2019 Nov;139(11):2334-2342.e8. doi: 10.1016/j.jid.2019.05.008. Epub 2019 May 29.

PMID:
31150604
9.

Myopathy and scleromyxedema.

Soulages A, Tang HM, Pham-Ledard A, Négrier-Leibreich ML, Cosnard A, Duval F, Solé G, Carla L, Le Masson G, Mathis S.

J Neurol. 2019 Aug;266(8):2051-2059. doi: 10.1007/s00415-019-09379-w. Epub 2019 May 21. Review.

PMID:
31115676
10.

Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma.

Leroy V, Gerard E, Dutriaux C, Prey S, Gey A, Mertens C, Beylot-Barry M, Pham-Ledard A.

Cancer Immunol Immunother. 2019 Apr;68(4):545-551. doi: 10.1007/s00262-019-02298-9. Epub 2019 Jan 19.

PMID:
30661086
11.

Three cases of bacterial osteomyelitis associated with hidradenitis suppurativa.

Blaizot R, Fernandez P, Cogrel O, Beylot-Barry M, Pham-Ledard A.

Br J Dermatol. 2019 Jun;180(6):1537-1538. doi: 10.1111/bjd.17593. Epub 2019 Feb 4. No abstract available.

PMID:
30588606
12.

Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis.

Dequidt L, Dousset L, Pham-Ledard A, Doutre MS, Beylot-Barry M.

JAAD Case Rep. 2018 Nov 27;5(1):1-4. doi: 10.1016/j.jdcr.2018.07.020. eCollection 2019 Jan. No abstract available.

13.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Guenova E, Child F, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Koletsa T, Jonak C, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Beylot-Barry M, Pham-Ledard A, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Trautinger F, Latzka J, Yoo J, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen MD, Battistella M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Vakeva L, Ranki A, Busschots AM, Hauben E, Bervoets A, Woei-A-Jin FJSH, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Arumainathan A, Azurdia R, Benstead K, Twigger R, Rieger K, Brown R, Sanches JA, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco FM, Querfeld C, Folkes A, Bur C, Klemke CD, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Willemze R.

Br J Dermatol. 2019 Aug;181(2):350-357. doi: 10.1111/bjd.17258. Epub 2018 Nov 25.

PMID:
30267549
14.

Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study.

Blaizot R, Ouattara E, Fauconneau A, Beylot-Barry M, Pham-Ledard A.

Br J Dermatol. 2018 Dec;179(6):1322-1328. doi: 10.1111/bjd.17073. Epub 2018 Oct 12.

PMID:
30098016
15.

A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.

Beylot-Barry M, Mermin D, Maillard A, Bouabdallah R, Bonnet N, Duval-Modeste AB, Mortier L, Ingen-Housz-Oro S, Ram-Wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Joly P, Vergier B, Vially PJ, Gros A, Pham-Ledard A, Frison E, Merlio JP.

J Invest Dermatol. 2018 Sep;138(9):1982-1989. doi: 10.1016/j.jid.2018.03.1516. Epub 2018 Mar 27.

16.

Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas.

Menguy S, Frison E, Prochazkova-Carlotti M, Dalle S, Dereure O, Boulinguez S, Dalac S, Machet L, Ram-Wolff C, Verneuil L, Gros A, Vergier B, Beylot-Barry M, Merlio JP, Pham-Ledard A.

Mod Pathol. 2018 Aug;31(8):1332-1342. doi: 10.1038/s41379-018-0041-7. Epub 2018 Mar 26.

17.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.

Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM.

Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16.

PMID:
29146737
18.

PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Menguy S, Prochazkova-Carlotti M, Beylot-Barry M, Saltel F, Vergier B, Merlio JP, Pham-Ledard A.

Am J Surg Pathol. 2018 Mar;42(3):326-334. doi: 10.1097/PAS.0000000000000983.

PMID:
29112015
19.

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.

Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C; GCC (French Group of Skin Cancer).

J Invest Dermatol. 2018 Jan;138(1):58-67. doi: 10.1016/j.jid.2017.07.839. Epub 2017 Aug 24.

20.

Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type.

Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Laforet MP, Beylot-Barry M, Vergier B, Parrens M, Feuillard J, Merlio JP, Gachard N.

J Dermatol Sci. 2017 Nov;88(2):238-246. doi: 10.1016/j.jdermsci.2017.07.008. Epub 2017 Jul 26.

PMID:
28838616
21.

Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.

Rousset M, Dutriaux C, Bosco-Lévy P, Prey S, Pham-Ledard A, Dousset L, Gérard E, Bouchet S, Canal-Raffin M, Titier K, Molimard M.

Clin Chim Acta. 2017 Sep;472:26-29. doi: 10.1016/j.cca.2017.07.012. Epub 2017 Jul 12.

PMID:
28709799
22.

[Treatment of Hailey-Hailey disease with botulinic toxin: A retrospective study of 8 cases].

Dousset L, Pham-Ledard A, Doutre MS, Beylot-Barry M, Cogrel O.

Ann Dermatol Venereol. 2017 Oct;144(10):599-606. doi: 10.1016/j.annder.2017.05.014. Epub 2017 Jun 29. French.

PMID:
28669425
23.

18F-FDG PET/CT Imaging of Popliteal Vasculitis Associated With Polyarteritis Nodosa.

Schollhammer R, Schwartz P, Jullie ML, Pham-Ledard A, Mercie P, Fernandez P, Pinaquy JB.

Clin Nucl Med. 2017 Aug;42(8):e385-e387. doi: 10.1097/RLU.0000000000001711.

PMID:
28574878
24.

Central nervous system involvement of primary cutaneous diffuse large B-cell lymphoma, leg type: 13 cases.

Gardette E, Maraval A, Brunet-Possenti F, Quereux G, Beltraminelli H, Templier I, Hodel J, Scherman E, Durot E, Bagot M, Pham-Ledard A, Grange F, Beylot-Barry M, Ingen-Housz-Oro S.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e498-e501. doi: 10.1111/jdv.14358. Epub 2017 Jun 15. No abstract available.

PMID:
28543967
25.

Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients.

Ingen-Housz-Oro S, Pham-Ledard A, Brice P, Lebrun-Vignes B, Zehou O, Reitter D, Ram-Wolff C, Dupin N, Bagot M, Chosidow O, Beylot-Barry M.

Eur J Dermatol. 2017 Jun 1;27(3):271-274. doi: 10.1684/ejd.2017.2986.

PMID:
28524061
26.

Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.

Mareschal S, Pham-Ledard A, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Fontanilles M, Bohers E, Ruminy P, Tournier I, Courville P, Lenormand B, Duval AB, Andrieu E, Verneuil L, Vergier B, Tilly H, Joly P, Frebourg T, Beylot-Barry M, Merlio JP, Jardin F.

J Invest Dermatol. 2017 Sep;137(9):1984-1994. doi: 10.1016/j.jid.2017.04.010. Epub 2017 May 4.

27.

Paradoxical psoriasiform reactions to antitumour necrosis factor-α drugs in hidradenitis suppurativa.

Dequidt L, Cogrel O, Guillet S, Milpied B, Darrigade AS, Beylot-Barry M, Pham-Ledard A.

Br J Dermatol. 2018 Jan;178(1):281-283. doi: 10.1111/bjd.15616. Epub 2017 Nov 10. No abstract available.

PMID:
28444990
28.

An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients.

Rousset M, Titier K, Bouchet S, Dutriaux C, Pham-Ledard A, Prey S, Canal-Raffin M, Molimard M.

Clin Chim Acta. 2017 Jul;470:8-13. doi: 10.1016/j.cca.2017.04.009. Epub 2017 Apr 12.

PMID:
28412197
29.

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.

Gros A, Laharanne E, Vergier M, Prochazkova-Carlotti M, Pham-Ledard A, Bandres T, Poglio S, Berhouet S, Vergier B, Vial JP, Chevret E, Beylot-Barry M, Merlio JP.

PLoS One. 2017 Mar 16;12(3):e0173171. doi: 10.1371/journal.pone.0173171. eCollection 2017.

30.

[Cutaneous granular bacteriosis occurring in Staphylococcus aureus septicaemia].

Mermin D, Védie AL, Jullie ML, Fauconneau A, Beylot-Barry M, Pham-Ledard A.

Ann Dermatol Venereol. 2017 Apr;144(4):275-278. doi: 10.1016/j.annder.2016.09.679. Epub 2016 Dec 26. French.

PMID:
28034470
31.

Anti-PD1-induced psoriasis: a study of 21 patients.

Bonigen J, Raynaud-Donzel C, Hureaux J, Kramkimel N, Blom A, Jeudy G, Breton AL, Hubiche T, Bedane C, Legoupil D, Pham-Ledard A, Charles J, Pérol M, Gérard E, Combemale P, Bonnet D, Sigal ML, Mahé E; Groupe de Recherche sur le Psoriasis and the Groupe Cancérologie Cutanée of the Société Française de Dermatologie the GEM Resopso, Apsoderm and the Groupe Français de Pneumo-Cancérologie.

J Eur Acad Dermatol Venereol. 2017 May;31(5):e254-e257. doi: 10.1111/jdv.14011. Epub 2016 Nov 7. No abstract available.

PMID:
27739129
32.

Pyoderma gangrenosum with extensive pulmonary involvement.

Scherlinger M, Guillet S, Doutre MS, Beylot-Barry M, Pham-Ledard A.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e214-e216. doi: 10.1111/jdv.13976. Epub 2016 Oct 12. No abstract available.

PMID:
27658239
33.

Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.

Mélard P, Idrissi Y, Andrique L, Poglio S, Prochazkova-Carlotti M, Berhouet S, Boucher C, Laharanne E, Chevret E, Pham-Ledard A, De Souza Góes AC, Guyonnet-Duperat V, Bibeyran A, Moreau-Gaudry F, Vergier B, Beylot-Barry M, Merlio JP, Cappellen D.

Oncotarget. 2016 Oct 18;7(42):68734-68748. doi: 10.18632/oncotarget.11930.

34.

Intravenous cidofovir for diffuse genital warts in the setting of multifactorial immunosuppression.

Blaizot R, Dutkiewicz AS, Guillet S, Pham-Ledard A, Beylot-Barry M.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e162-e163. doi: 10.1111/jdv.13880. Epub 2016 Aug 16. No abstract available.

PMID:
27527116
35.

[Latent-disseminated tuberculosis revealed by atypical skin ulcerations].

Ferrati-Fidelin G, Pham-Ledard A, Fauconneau A, Chauvel A, Houard C, Doutre MS, Beylot-Barry M.

Ann Dermatol Venereol. 2016 Oct;143(10):616-621. doi: 10.1016/j.annder.2016.05.003. Epub 2016 Jun 21. French.

PMID:
27342431
36.

MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.

Menguy S, Gros A, Pham-Ledard A, Battistella M, Ortonne N, Comoz F, Balme B, Szablewski V, Lamant L, Carlotti A, Lorton MH, de Muret A, Le Gall F, Franck F, Croue A, Cappellen D, Beylot-Barry M, Merlio JP, Vergier B.

J Invest Dermatol. 2016 Aug;136(8):1741-1744. doi: 10.1016/j.jid.2016.04.018. Epub 2016 May 14. No abstract available.

37.

[Primary localized cutaneous nodular amyloidosis: A diagnostic and therapeutic challenge].

Gérard E, Ly S, Cogrel O, Pham-Ledard A, Fauconneau A, Penchet I, Ouhabrache N, Vergier B, Beylot-Barry M.

Ann Dermatol Venereol. 2016 Feb;143(2):134-8. doi: 10.1016/j.annder.2015.10.596. Epub 2015 Dec 24. French.

PMID:
26724842
38.

Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis.

Marti A, Fauconneau A, Ouhabrache N, Beylot-Barry M, Pham-Ledard A.

JAMA Dermatol. 2016 Mar;152(3):343-5. doi: 10.1001/jamadermatol.2015.4134. No abstract available.

PMID:
26606112
39.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

40.

PLCG1 Gene Mutations Are Uncommon in Cutaneous T-Cell Lymphomas.

Caumont C, Gros A, Boucher C, Mélard P, Prochazkova-Carlotti M, Laharanne E, Pham-Ledard A, Vergier B, Chevret E, Beylot-Barry M, Merlio JP, Cappellen D.

J Invest Dermatol. 2015 Sep;135(9):2334-2337. doi: 10.1038/jid.2015.161. Epub 2015 Apr 24. No abstract available.

41.

Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.

Pham-Ledard A, Cowppli-Bony A, Doussau A, Prochazkova-Carlotti M, Laharanne E, Jouary T, Belaud-Rotureau MA, Vergier B, Merlio JP, Beylot-Barry M.

Am J Clin Pathol. 2015 Mar;143(3):362-73. doi: 10.1309/AJCP4SUBR4NPSPTN.

PMID:
25696794
42.

Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases.

Fauconneau A, Pham-Ledard A, Cappellen D, Frison E, Prochazkova-Carlotti M, Parrens M, Dalle S, Joly P, Viraben R, Franck F, Ingen-Housz-Oro S, Giacchero D, Jullié ML, Vergier B, Merlio JP, Beylot-Barry M.

Br J Dermatol. 2015 Jun;172(6):1547-1554. doi: 10.1111/bjd.13690. Epub 2015 May 16.

PMID:
25645336
43.

High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.

Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B, Martinez F, Cappellen D, Merlio JP, Grange F.

JAMA Dermatol. 2014 Nov;150(11):1173-9. doi: 10.1001/jamadermatol.2014.821.

PMID:
25055137
44.

[Two cases of proliferation of monoclonal and monotypic lymphocytes and plasma cells corresponding to acrodermatitis chronica atrophicans].

Bertolotti A, Pham-Ledard A, Petrot D, Coindre MC, Brecheteau P, Mendes I, Vergier B, Beylot-Barry M.

Ann Dermatol Venereol. 2014 Jun-Jul;141(6-7):452-7. doi: 10.1016/j.annder.2014.04.117. Epub 2014 Jun 2. French.

PMID:
24951145
45.

BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis.

Chaminade A, Conte H, Jouary T, Fauconneau A, Darrigade AS, Beylot-Barry M, Pham-Ledard A.

J Eur Acad Dermatol Venereol. 2015 Feb;29(2):392-3. doi: 10.1111/jdv.12397. Epub 2014 Feb 17. No abstract available.

PMID:
24533578
46.

Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.

Chevret E, Andrique L, Prochazkova-Carlotti M, Ferrer J, Cappellen D, Laharanne E, Idrissi Y, Boettiger A, Sahraoui W, Ruiz F, Pham-Ledard A, Vergier B, Belloc F, Dubus P, Beylot-Barry M, Merlio JP.

Blood. 2014 Mar 20;123(12):1850-9. doi: 10.1182/blood-2013-05-500686. Epub 2014 Jan 27.

PMID:
24470590
47.

Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.

Pham-Ledard A, Prochazkova-Carlotti M, Andrique L, Cappellen D, Vergier B, Martinez F, Grange F, Petrella T, Beylot-Barry M, Merlio JP.

Mod Pathol. 2014 Mar;27(3):402-11. doi: 10.1038/modpathol.2013.156. Epub 2013 Sep 13.

48.

Lymphomatoid papulosis type D: an aggressive histology for an indolent disease.

Bertolotti A, Pham-Ledard AL, Vergier B, Parrens M, Bedane C, Beylot-Barry M.

Br J Dermatol. 2013 Nov;169(5):1157-9. doi: 10.1111/bjd.12463. Review. No abstract available.

PMID:
23746266
49.

MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type.

Pham-Ledard A, Cappellen D, Martinez F, Vergier B, Beylot-Barry M, Merlio JP.

J Invest Dermatol. 2012 Aug;132(8):2118-20. doi: 10.1038/jid.2012.102. Epub 2012 Apr 12. No abstract available.

50.

First report of topical timolol treatment in primarily ulcerated perineal haemangioma.

Cante V, Pham-Ledard A, Imbert E, Ezzedine K, Léauté-Labrèze C.

Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F155-6. doi: 10.1136/fetalneonatal-2011-301317. Epub 2011 Dec 21. No abstract available.

PMID:
22190187

Supplemental Content

Loading ...
Support Center